Randall Kramer

USPTO Granted Patents = 27 (Patent Applications = 4)

EPO Patents = 7 (Patent Applications = 12)

Average Co-Inventor Count = 3.2

ph-index = 6

Forward Citations = 90(Granted Patents)

Company Filing History:

where one patent can have more than one assignee

Years Active: 2010-2020

Loading Chart...

27 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10626386 - Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same (2020-04-21),

2. 10246693 - Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same (2019-04-02),

3. 10167461 - Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same (2019-01-01),

4. 10035828 - Methods of using polypeptides having cellulolytic enhancing activity (2018-07-31),

5. 10006012 - Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same (2018-06-26),

6. 9994832 - Recombinant host cell expressing a family glycoside hydrolase 61 polypeptide (2018-06-12),

7. 9765372 - Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same (2017-09-19),

8. 9725489 - Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same (2017-08-08),

9. 9605037 - Recombinant host cells and nucleic acid constructs encoding polypeptides having cellulolytic enhancing activity (2017-03-28),

10. 9506049 - Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same (2016-11-29),

11. 9410136 - Methods for enhancing the degradation or conversion of cellulosic material (2016-08-09),

12. 9409958 - Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same (2016-08-09),

13. 9303074 - Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same (2016-04-05),

14. 8865446 - Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same (2014-10-21),

15. 8865445 - Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same (2014-10-21),

Title: The Innovations of Randall Kramer: A Pioneer in Cellulolytic Enhancements

Introduction: Randall Kramer, based in Lincoln, California, is a distinguished inventor recognized for his profound contributions to the field of biotechnology, particularly in cellulolytic enhancements. With an impressive portfolio of 27 patents, Kramer's innovative work has significantly impacted research and development in this domain.

Latest Patents: Among his latest patents, Kramer has developed a groundbreaking invention involving polypeptides that exhibit cellulolytic enhancing activity and the corresponding polynucleotides that encode them. This invention not only includes isolated polypeptides but also nucleic acid constructs, vectors, and host cells that contain these polynucleotides. Furthermore, the patented methods for producing and utilizing these polypeptides demonstrate the practical applicability of his research.

Career Highlights: Kramer's career has been marked by his affiliation with renowned companies such as Novozymes, Inc. and Novozymes A/S, where he has played a crucial role in advancing biotechnological innovations. His extensive experience in these leading firms has solidified his reputation as a key innovator in the field.

Collaborations: Throughout his career, Randall has collaborated with esteemed colleagues, including Lan Tang and Ye Liu, fostering a collaborative environment that emphasizes the importance of teamwork in driving cutting-edge research and development.

Conclusion: Randall Kramer stands as a testament to innovation in the biotechnology sector. His numerous patents and collaborations reflect his commitment to enhancing cellulolytic processes and furthering scientific understanding. As the field continues to evolve, Kramer's contributions will undoubtedly remain influential in shaping the future of biotechnological advancements.

This text is generated by artificial intelligence and may not be accurate.